Literature DB >> 1642127

Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden.

G Isacsson1, G Boëthius, U Bergman.   

Abstract

The use of antidepressants has been low in Jämtland County for many years, while the suicide rate has been among the highest in Sweden. A continuous outpatient prescription recording system has been in operation in Jämtland since 1970. Through this system we traced the prescription pattern of 80 individuals who committed suicide from 1970 to 1984. Suicide patients obtained 1.5 times more prescription drugs than 80 matched controls, mainly psychotropics and vitamins. During the 3 months prior to the suicide, half of the patients had received medical attention and 73% of the women and 40% of the men had obtained prescription drugs, in one-third from the psychiatric department. While 53% and 29%, respectively, obtained psychotropic drugs, only 13% and 9% respectively were prescribed antidepressants, often in low doses. People who will commit suicide often seek medical help. The low rate of antidepressant prescription in patients committing suicide probably reflects insufficient diagnosis and treatment of depressive disorders. It is urgent--for the individual as well as for society--that diagnostic and pharmacotherapeutic routines be improved.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642127     DOI: 10.1111/j.1600-0447.1992.tb03209.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

Review 1.  Management of patients who deliberately harm themselves.

Authors:  G Isacsson; C L Rich
Journal:  BMJ       Date:  2001-01-27

Review 2.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

3.  Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide.

Authors:  Robert D Gibbons; Eisuke Segawa; George Karabatsos; Anup K Amatya; Dulal K Bhaumik; C Hendricks Brown; Kush Kapur; Sue M Marcus; Kwan Hur; J John Mann
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373

Review 4.  Antidepressant drugs and the risk of suicide in children and adolescents.

Authors:  Göran Isacsson; Charles L Rich
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 5.  Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

6.  Treatment of Veterans with depression who died by suicide: timing and quality of care at last Veterans Health Administration visit.

Authors:  Eric G Smith; Thomas J Craig; Dara Ganoczy; Heather M Walters; Marcia Valenstein
Journal:  J Clin Psychiatry       Date:  2010-09-07       Impact factor: 4.384

7.  Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden.

Authors:  G Isacsson; I Redfors; D Wasserman; U Bergman
Journal:  BMJ       Date:  1994-12-10

8.  Use of antidepressants among people committing suicide in Sweden.

Authors:  G Isacsson; P Holmgren; D Wasserman; U Bergman
Journal:  BMJ       Date:  1994-02-19

9.  Predictors of serious suicidal behavior in late-life depression.

Authors:  Katalin Szanto; Hanga Galfalvy; Laura Kenneally; Rebeka Almasi; Alexandre Y Dombrovski
Journal:  Eur Neuropsychopharmacol       Date:  2020-08-07       Impact factor: 4.600

Review 10.  Indicators of patients with major depressive disorder in need of highly specialized care: A systematic review.

Authors:  Frédérique C W van Krugten; Meriam Kaddouri; Maartje Goorden; Anton J L M van Balkom; Claudi L H Bockting; Frenk P M L Peeters; Leona Hakkaart-van Roijen
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.